Peripheral perfusion and tissue oxygenation improvement induced by antihypertensive medication combined with lipoidoproteinosis treatment.
Cicco
G
G
Department of Internal Medicine and Oncology, Hypertension Center, University of Bari, Italy.
Vicenti
P
P
Pirrelli
A
A
van der Kleij
A J
AJ
D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005080:Exercise Test; D005260:Female; D017328:Fosinopril / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D008065:Lipoid Proteinosis of Urbach and Wiethe / Q000150:complications / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D008833:Microcirculation / Q000187:drug effects; D008875:Middle Aged; D010100:Oxygen / Q000378:metabolism*; D017035:Pravastatin / Q000008:administration & dosage / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D017035:Pravastatin; D017328:Fosinopril; D010100:Oxygen